HEPATO CELLULAR CARCINOMA (HCC)
Clinical trials for HEPATO CELLULAR CARCINOMA (HCC) explained in plain language.
Never miss a new study
Get alerted when new HEPATO CELLULAR CARCINOMA (HCC) trials appear
Sign up with your email to follow new studies for HEPATO CELLULAR CARCINOMA (HCC), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Liver cancer trial aims to boost standard treatment with blood pressure drug
Disease control Recruiting nowThis study tests whether adding a blood pressure drug (nicardipine) to a standard liver cancer treatment (TACE) can improve outcomes. About 152 adults with liver cancer will receive either TACE plus nicardipine or TACE alone. The goal is to see if the combination shrinks tumors m…
Matched conditions: HEPATO CELLULAR CARCINOMA (HCC)
Phase: PHASE2, PHASE3 • Sponsor: University Hospital, Basel, Switzerland • Aim: Disease control
Last updated Jun 15, 2026 19:03 UTC
-
New drug shows promise for tough liver cancer cases
Disease control Recruiting nowThis study tests a drug called Becotatug vedotin in 40 adults with advanced liver cancer that has worsened after standard treatments. The goal is to see if it can shrink tumors and help control the disease. Participants receive the drug and are monitored for safety and response.
Matched conditions: HEPATO CELLULAR CARCINOMA (HCC)
Phase: PHASE2 • Sponsor: Fudan University • Aim: Disease control
Last updated Jun 15, 2026 18:55 UTC
-
New drug duo aims to slow advanced liver cancer
Disease control Recruiting nowThis study tests whether adding chemotherapy to a two-drug combination (camrelizumab and apatinib) helps people with advanced liver cancer live longer without their disease getting worse. About 326 adults with liver cancer that cannot be removed by surgery will be randomly assign…
Matched conditions: HEPATO CELLULAR CARCINOMA (HCC)
Phase: PHASE3 • Sponsor: Linhui Peng • Aim: Disease control
Last updated Jun 11, 2026 12:10 UTC
-
New hope for liver cancer patients: smart trial seeks best Second-Line therapy
Disease control Recruiting nowThis study tests several new drug combinations for people with advanced liver cancer (hepatocellular carcinoma) whose first treatment stopped working. About 350 adults will receive one of the experimental therapies, and researchers will use scans, blood tests, and tumor samples t…
Matched conditions: HEPATO CELLULAR CARCINOMA (HCC)
Phase: PHASE2 • Sponsor: Fudan University • Aim: Disease control
Last updated Jun 08, 2026 13:10 UTC
-
Poop pills may rescue liver cancer patients when drugs fail
Disease control Recruiting nowThis study tests whether a fecal microbiota transplant (FMT) can help people with advanced liver cancer whose disease got worse on standard immunotherapy. About 15 adults will receive FMT along with restarting their cancer drugs. The goal is to see if this combination can control…
Matched conditions: HEPATO CELLULAR CARCINOMA (HCC)
Phase: PHASE2 • Sponsor: IRCCS Azienda Ospedaliero-Universitaria di Bologna • Aim: Disease control
Last updated May 29, 2026 14:18 UTC
-
New blood test could sniff out liver cancer before It's too late
Diagnosis Recruiting nowThis study is testing a new blood test called Delta-HLD to see if it can accurately detect liver cancer (hepatocellular carcinoma). Researchers will compare results from 200 people—half with liver cancer and half with cirrhosis but no cancer—to measure how sensitive and specific …
Matched conditions: HEPATO CELLULAR CARCINOMA (HCC)
Sponsor: Epiliquid Holding, Inc • Aim: Diagnosis
Last updated Jun 08, 2026 13:04 UTC
-
Could liver cancer patients skip the hospital stay? new trial tests outpatient care
Symptom relief Recruiting nowThis study tests whether people with liver cancer can receive a treatment that goes through an artery (like chemo or radiation beads) as an outpatient instead of staying in the hospital. About 206 adults with liver cancer will be randomly assigned to either outpatient or standard…
Matched conditions: HEPATO CELLULAR CARCINOMA (HCC)
Phase: NA • Sponsor: University Hospital, Angers • Aim: Symptom relief
Last updated Jun 16, 2026 22:34 UTC
-
Simple gel may prevent painful side effect of liver cancer drug
Symptom relief Recruiting nowThis study tests if applying a topical gel (indomethacin) to the hands before starting sorafenib can prevent or reduce hand-foot skin reactions, a common and painful side effect. About 39 adults with advanced liver cancer will use the gel twice daily for up to 12 weeks. The goal …
Matched conditions: HEPATO CELLULAR CARCINOMA (HCC)
Phase: PHASE2 • Sponsor: National Taiwan University Hospital • Aim: Symptom relief
Last updated Jun 01, 2026 18:04 UTC